Buscar

Mostrando ítems 1-10 de 2551

The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors

Reyes-Parada M.; Iturriaga-Vasquez P. (Taylor and Francis Ltd, 2016)

Fiat money and the value of binding portfolio constraints

Páscoa, Mário R.; Petrassi, Myrian; Torres Martínez, Juan Pablo (Springer, 2011-02)

We establish necessary and sufficient conditions for the individual optimality of a consumption-portfolio plan in an infinite horizon economy where agents are uniformly impatient and fiat money is the only asset available ...

Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein

Universidade Estadual Paulista (Unesp); Universidade do Oeste de Santa Catarina (UNOESC) (2005-05-01)

Bacterial DNA gyrase, has been identified as the target of several antibacterial agents, including the coumarin drugs. The coumarins inhibit the gyrase action by competitive binding to the ATP-binding site of DNA gyrase B ...

Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein

Universidade Estadual Paulista (Unesp); Universidade do Oeste de Santa Catarina (UNOESC) (2005-05-01)

New therapeutic property of dimebon as a neuroprotective agent

Ustyugov A.; Shevtsova E.; Barreto G.E.; Ashraf G.M.; Bachurin S.O.; Aliev G. (Bentham Science Publishers B.V., 2018)

Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy

Iturriaga-Vásquez P.; Alzate-Morales J.; Bermudez I.; Varas R.; Reyes-Parada M. (Academic Press, 2015)

Structure/activity analysis of task-3 channel antagonists based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine

Ramírez D.; Bedoya M.; Kiper A.K.; Rinné S.; Morales-Navarro S.; Hernández-Rodríguez E.W.; Sepúlveda F.V.; Decher N.; González W. (MDPI AG, 2019)

GABAA Receptor Binding and Ion Channel Function in Primary Neuronal Cultures for Neuropharmacology/Neurotoxicity Testing

Suñol, Cristina; Garcia, Daniel Asmed (Humana Press, 2011)

GABAA receptor (GABAAR) constitutes the main inhibitory receptor of the central nervous system. Due to the wide distribution and activity of its main neurotransmitter agonist, the γ-aminobutyric acid (GABA), its pharmacology ...

Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein

Garrido, Saulo Santesso; Scatigno, A. C.; Trovatti, E.; Carvalho, D. C.; Marchetto, Reinaldo (2014)

Molecular docking and drug discovery in β-adrenergic receptors

Vilar S.; Sobarzo-Sanchez E.; Santana L.; Uriarte E. (Bentham Science Publishers B.V., 2017)

1
2
3
4
. . .
256

Buscar

Filtros

The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors

Fiat money and the value of binding portfolio constraints

Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein

Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein

New therapeutic property of dimebon as a neuroprotective agent

Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy

Structure/activity analysis of task-3 channel antagonists based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine

GABAA Receptor Binding and Ion Channel Function in Primary Neuronal Cultures for Neuropharmacology/Neurotoxicity Testing

Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein

Molecular docking and drug discovery in β-adrenergic receptors